Timo Hildén, The former CEO and President of The Revenio Group, has been appointed the new Chairman of the Board. Alongside Timo, Frans Wuite and Tommi Mäkelä strengthen Nukute’s strategic competence in dealing with the global medtech market. From the previous board of directors, the distinguished gentlemen Johannes Gullichsen, Pekka Virtanen and Timo T. Laitinen continue as members.